10X Capital Venture Acquisition Corp. III
VCXBDelisted Jul 26, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001848948
10X Capital Venture Acquisition Corp. III was delisted on Jul 26, 2024; its insiders filed their last Form 4 on Mar 11, 2022; 11 institutions reported holding it in 13F filings for Q2 2024, worth $21.4M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding 10X Capital Venture Acquisition Corp. III changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 17 | 22 | +5 |
| Shares | 4.00M | 4.02M | +16.2K (+0.4%) |
| Value | $41.2M | $42.1M | +$858.6K (+2.1%) |
New holders (6)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mizuho Securities USA LLC | 115,706 | $1.21M | 0.04% |
| Highbridge Capital Management LLC | 85,750 | $898.7K | 0.05% |
| HRT Financial LP | 28,258 | $296.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 19,251 | $201.8K | 0.00% |
| Virtu Financial LLC | 10,556 | $111.0K | 0.01% |
| Barclays PLC | 7,400 | $77.6K | 0.00% |
Sold out (1)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| UBS Group AG | 400 | $4.10K |